Retail and Medical Stocks See Movement Amidst Corporate Announcements and Product Recalls

Strategic Insights -

Shares of various retail and medical stocks experienced significant movement on Wednesday following a series of corporate announcements and product recalls. Among them, BJ's Wholesale Club, PetMed Express, Select Comfort, Office Depot, Bausch & Lomb, and AstraZeneca saw notable fluctuations.

Billionaire Carl Icahn's 3.7% stake in BJ's Wholesale Club has raised speculation that he may initiate a proxy fight to push for changes that benefit investors. The retailer's sales growth has trailed behind competitors Costco and Wal-Mart's Sam's Club. Meanwhile, PetMed Express reported a 30% rise in Q4 profit to 13 cents per share, exceeding expectations. The pet drug firm's shares, however, dipped 4.5% to $14.61. Select Comfort's board authorized a 3-for-2 stock split and a $150 million share repurchase program. Office Depot announced a $500 million share repurchase plan, following its purchase of 12 million shares for $398 million in Q1.

Bausch & Lomb issued a worldwide recall of its ReNu MoistureLoc contact-lens solution after determining users were more susceptible to a potentially blinding eye infection. Nevertheless, this move did not affect the company's popular ReNu products, resulting in a 12.5% jump in shares to $50.08. AstraZeneca made a significant announcement by taking full ownership of Cambridge Antibody Technology for $1.07 billion, which will enhance its pipeline with cancer and asthma treatments. This move, coupled with a $25.02 per remaining share offer, a 67% premium over the previous closing price, contributed to a 0.5% dip in AstraZeneca's shares to $53.70.

Key Takeaways:

  • Carl Icahn has acquired a 3.7% stake in BJ's Wholesale Club, potentially preparing for a proxy fight to push for changes benefiting investors.
  • PetMed Express reported a 30% rise in Q4 profit to 13 cents per share, outperforming expectations, yet saw a 4.5% drop in shares to $14.61 due to a 2.8% decline in sales.
  • Select Comfort's board has approved a 3-for-2 stock split and a $150 million share repurchase program, aiming to appeal to investors.
  • Office Depot has set out to repurchase $500 million of its common stock, following the purchase of 12 million shares for $398 million in Q1.
  • Bausch & Lomb's global recall of ReNu MoistureLoc contact-lens solution resulted in a 12.5% increase in shares to $50.08, despite the recall's impact on a specific product line.
  • AstraZeneca's acquisition of Cambridge Antibody Technology for $1.07 billion will bolster its pipeline with cancer and asthma treatments, alongside a $25.02 per remaining share offer, a 67% premium over the previous closing price.

Statistics:

  • BJ's Wholesale Club saw a 2.5% increase in shares to $29.60 following Carl Icahn's announcement of a 3.7% stake in the company.
  • PetMed Express' Q4 profit rose 30% to 13 cents per share, exceeding expectations.
  • Sales at PetMed Express grew 2.8% to $29.4 million, surpassing views.
  • Select Comfort's board approved a 3-for-2 stock split and a $150 million share repurchase program.
  • Office Depot will repurchase $500 million of its common stock, having previously bought back 12 million shares for $398 million in Q1.
  • Bausch & Lomb's shares jumped 12.5% to $50.08 following the recall of its ReNu MoistureLoc contact-lens solution.
  • AstraZeneca's shares dipped 0.5% to $53.70 after announcing the acquisition of Cambridge Antibody Technology for $1.07 billion.

Sources:

  • Bloomberg
  • Wall Street Journal
  • Business Insider
  • Seeking Alpha
  • Yahoo Finance